🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to learn about 2 types of FDA-approve...
Status
Withdrawn
Location
University of Miami
Start Date
2018-05
Trial ID
NCT03345225
Treatments Being Tested
The goal of this clinical research trial is to study the use of differing i...
Status
Recruiting
Location
The New York Proton Center
Start Date
2022-01-24
Trial ID
NCT05313191
Treatments Being Tested
In this study, the investigators are to prospectively evaluate patient's su...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01432314
Treatments Being Tested
Background: \- Tremelimumab is a cancer treatment drug that helps the immu...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-05-02
Trial ID
NCT01853618
Treatments Being Tested
This study is for patients with locally advanced sinonasal adenoid cystic c...
Status
Recruiting
Location
Eye and ENT Hospital, Fudan University
Start Date
2026-01-20
Trial ID
NCT07320508
Treatments Being Tested
TACE is widely used in patients with unresectable HCC. However, it is a non...
Status
Unknown
Location
Shandong Medical Imaging Research Institute
Start Date
2012-07
Trial ID
NCT01605734
Treatments Being Tested
This is a real world study to determine the short-term efficacy and safety ...
Status
Unknown
Location
Huai He Hospital of Henan University
Start Date
2023-09-10
Trial ID
NCT06023147
Treatments Being Tested
To clarify the safety and efficacy of using uniform-sized drug-loaded embol...
Status
Not Yet Recruiting
Location
People's Hospital of Kaiyang County
Start Date
2025-10-10
Trial ID
NCT07180459
RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blockin...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2009-07-22
Trial ID
NCT01011010
Hepatocellular carcinoma (HCC) is the 6th most common cancer and the third ...
Status
Completed
Location
Cancer Centre of Sun Yat-Sen University
Start Date
2010-01
Trial ID
NCT01833299
Treatments Being Tested